Senolytics reduce COVID-19 symptoms in preclinical studies
(Press-News.org) ROCHESTER, Minn. -- Mayo Clinic researchers and colleagues at the University of Minnesota showed that COVID-19 exacerbates the damaging impact of senescent cells in the body. In preclinical studies, the senolytic drugs discovered at Mayo significantly reduced inflammation, illness, and mortality from COVID infection in older mice. The findings appear in the journal Science.
Senescent cells (damaged or non-functioning cells that persist in the body) contribute to many aspects of aging and illness, including inflammation and multiple chronic diseases. Based on the "Amplifier/Rheostat Hypothesis" of senescent cells developed at Mayo, the researchers sought to discover how COVID-19 causes much higher mortality in the elderly and chronically-ill. They showed that human senescent cells have an amplified response to the SARS spike protein, provoking increased production of factors causing inflammation and tissue damage by senescent cells.
The researchers also found that older mice infected with viruses, including a coronavirus related to SARS-CoV-2 using a model developed at University of Minnesota, showed an amplified reaction, with increased senescent cells, inflammation, and nearly 100 % mortality. When the researchers treated similar mice - before or after the infection - with senolytics, drugs that selectively remove senescent cells from the body, the result was the opposite. Anti-viral antibodies increased, while signs of inflammation and senescent cells significantly decreased along with mortality, so survival of the old, infected mice became more like that of younger mice.
The researchers suggest that reducing the existing burden of senescent cells in older or chronically-diseased patients may increase their resilience and decrease their risk of dying from viral infections, including SARS-CoV-2. Three such clinical trials are now underway.
"Even though vaccine use is growing, senolytics could still be helpful to those who cannot receive the vaccine, and especially to older individuals in nursing homes with comorbidities or immunity issues," says James Kirkland, M.D., Ph.D., director of the Kogod Center on Aging and, together with Tamar Tchkonia, Ph.D., senior author for Mayo Clinic on the study. The study suggests senolytics could also improve response of the elderly to vaccines and help them fight bacterial and other viral infections.
The research was supported by the National Institutes of Health; the Connor Fund; Robert J. and Theresa W. Ryan; Robert P. and Arlene R. Kogod; the Noaber Foundation; the University of Minnesota Clinical and Translational Science Institute; the Medical Discovery Team on the Biology of Aging; and The Irene Diamond Fund/American Federation on Aging Research Postdoctoral Transition 10 Award. Also, by the Fesler-Lampert Chair in Aging Studies and the AFAR Junior Faculty Award.
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news. For information on COVID-19, including Mayo Clinic's Coronavirus Map tracking tool, which has 14-day forecasting on COVID-19 trends, visit the Mayo Clinic COVID-19 Resource Center.
Bob Nellis, Mayo Clinic Public Affairs, firstname.lastname@example.org
ELSE PRESS RELEASES FROM THIS DATE:
A study of the associations between drinking alcohol and the chances of becoming pregnant suggests that women who want to conceive should avoid heavy drinking. In the second half of menstrual cycle even moderate drinking is linked to reduced chances of pregnancy.
The study, published today (Wednesday) in Human Reproduction , one of the world's leading reproductive medicine journals, investigated alcohol intake and fecundability, which is defined as the probability of conceiving during a single menstrual cycle. It is the first study to look at this according to the difference phases of women's menstrual cycles.
Researchers led by Dr Kira Taylor, associate professor of epidemiology and population ...
As new research on anaesthesia trainee morale is published, an impassioned plea is today being made in an open letter from the Association of Anaesthetists to the UK's four Health Secretaries: to urgently double the number of training posts for anaesthetists this summer and for subsequent years so that the UK can safely negotiate the current COVID-19 pandemic, any future pandemics, and deal with the huge backlog of surgical procedures that has built up during lockdown.
The Association has sent a separate letter to go to each Health Secretary - Matt Hancock MP in the UK Department of Health, Humza Yousaf MSP in Scotland, Baroness Eluned Morgan MS in Wales, and Robin Swann MLA in ...
According to the National Alliance on Mental Illness and the World Health Organization, depression affects 16 million Americans and 322 million people worldwide. Emerging evidence suggests that the COVID-19 pandemic is further exacerbating the prevalence of depression in the general population. With this trajectory, it is evident that more effective strategies are needed for therapeutics that address this critical public health issue.
In a recent study, publishing in the June 9, 2021 online edition of Nature Translational Psychiatry, researchers at University of California San Diego School of Medicine used a combination of modalities, such as measuring brain function, cognition and lifestyle factors, to generate individualized predictions of depression.
The machine learning and personalized ...
In "Atchafalaya," John McPhee's essay in the 1989 book The Control of Nature, the author chronicles efforts by the U.S. Army Corps of Engineers to prevent the Atchafalaya River from changing the course of the Mississippi River where they diverge, due to the Atchafalaya's steeper gradient and more direct route to the gulf. McPhee's classic essay proved inspirational to John Shaw, an assistant professor of geosciences who called it "a foundational text."
Indeed, his latest work adds to the story.
In a recent paper published in the American Geophysical Union's journal, Water ...
Everyone is familiar with tiny gas bubbles gently rising up in sparkling water. But the bubbles that were created by intense focused lasers in this experiment were ten times smaller and contained water vapour at a pressure around a hundred thousand times higher. Under these conditions, the bubble expands at supersonic speed and pushes a shockwave, consisting of a spherical shell of highly compressed water, ahead of itself. Now the research team led by the University of Göttingen, together with the Deutsches Elektronen-Synchroton (DESY) and the European X-Ray Free-Electron Laser (European XFEL), has created such an event and then, with an innovative ...
The analysis of very old plant fossils discovered in South Africa and dating from the Lower Devonian period documents the transition from barren continents to the green planet we know today. Cyrille Prestianni, a palaeobotanist at the EDDy Lab at the University of Liège (Belgium), participated in this study, the results of which have just been published in the journal Scientific Reports.
The greening of continents - or terrestrialisation - is undoubtedly one of the most important processes that our planet has undergone. For most of the Earth's history, the continents were devoid of macroscopic ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--QurAlis Corporation, a biotech company developing breakthrough precision medicines for ALS and other genetically validated neurodegenerative diseases, today announced the publication of an article in Cell Reports titled Human Amyotrophic Lateral Sclerosis Excitability Phenotype Screen: Target Discovery and Validation by QurAlis founders Kasper Roet, Ph.D., Clifford Woolf, M.D., Ph.D., and Kevin Eggan, Ph.D., who pioneered a high-content, live-cell imaging screen using ALS patient-derived motor neurons in combination with a compound library generated by Pfizer to identify drug targets to treat hyperexcitability induced neurodegeneration ...
A research team from the University of Massachusetts Amherst has created an electronic microsystem that can intelligently respond to information inputs without any external energy input, much like a self-autonomous living organism. The microsystem is constructed from a novel type of electronics that can process ultralow electronic signals and incorporates a device that can generate electricity "out of thin air" from the ambient environment.
The groundbreaking research was published June 7 in the journal Nature Communications.
Jun Yao, an assistant professor in the electrical and computer engineering (ECE) and an adjunct professor in biomedical engineering, ...
DURHAM, N.C. - Using drones and artificial intelligence to monitor large colonies of seabirds can be as effective as traditional on-the-ground methods, while reducing costs, labor and the risk of human error, a new study finds.
Scientists at Duke University and the Wildlife Conservation Society (WCS) used a deep-learning algorithm--a form of artificial intelligence--to analyze more than 10,000 drone images of mixed colonies of seabirds in the Falkland Islands off Argentina's coast.
The Falklands, also known as the Malvinas, are home to the world's largest colonies of black-browed albatrosses (Thalassarche melanophris) and second-largest ...
Researchers from the University of Liège (Belgium) have recently developed a new artificial neuron inspired by the different modes of operation of human neurons. Called a Bistable Recurrent Cell (BRC), this process has enabled recurrent networks to learn temporal relationships of more than a thousand discrete time units where classical methods failed after only a hundred time units. These important results are published in the journal PLOS One.
The enormous interest in artificial intelligence (AI) in recent years has led to the development of extremely powerful machine learning techniques. For example, time series - any series of data where a time component is ...
LAST 30 PRESS RELEASES:
[Press-News.org] Senolytics reduce COVID-19 symptoms in preclinical studies